{
  "hash": "4f863505cc985c46043f043d22fdd8d3",
  "result": {
    "engine": "knitr",
    "markdown": "---\ntitle: \"Time to Positivity & Clinical Outcomes in Bacteremia\"\nsubtitle: \"A Bayesian Meta-Analysis\"\nauthor: \"Russell Lewis\"\ndate: \"February 13, 2026\"\n---\n\n::: {.hero-banner}\n# Blood Culture Time to Positivity as a Prognostic Marker\n\nThis comprehensive meta-analysis examines whether shorter blood culture time to positivity (TTP) predicts worse clinical outcomes in patients with bacteremia.\n:::\n\n## Executive Summary\n\nBlood culture time to positivity (TTP) — the interval between culture incubation and microbial growth detection — has emerged as a potential prognostic marker in bacteremia. Shorter TTP is hypothesized to reflect higher bacterial inocula, which may signal more severe infection and increased risk of adverse outcomes.\n\n### Primary Findings\n\n::: {.stat-box}\n### Mortality\n**Pooled OR: 2.14** (95% CrI: 1.69–2.79)\n\nBased on 33 studies with P(OR > 1) = 100%\n:::\n\n::: {.stat-box}\n### Persistent Bacteremia\n**Pooled OR: 4.02** (95% CrI: 1.08–11.11)\n\nBased on 7 studies with P(OR > 1) = 97.9%\n:::\n\n::: {.key-finding}\n**Key Finding:** Short TTP is robustly associated with increased mortality risk. The association remains significant across all sensitivity analyses, prior specifications, and publication bias adjustment methods.\n:::\n\n## Study Characteristics\n\n\n::: {.cell}\n\n:::\n\n\n\n::: {.cell}\n::: {.cell-output-display}\n\n```{=html}\n<div id=\"ohkkdbeqgg\" style=\"padding-left:0px;padding-right:0px;padding-top:10px;padding-bottom:10px;overflow-x:auto;overflow-y:auto;width:auto;height:auto;\">\n<style>#ohkkdbeqgg table {\n  font-family: system-ui, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';\n  -webkit-font-smoothing: antialiased;\n  -moz-osx-font-smoothing: grayscale;\n}\n\n#ohkkdbeqgg thead, #ohkkdbeqgg tbody, #ohkkdbeqgg tfoot, #ohkkdbeqgg tr, #ohkkdbeqgg td, #ohkkdbeqgg th {\n  border-style: none;\n}\n\n#ohkkdbeqgg p {\n  margin: 0;\n  padding: 0;\n}\n\n#ohkkdbeqgg .gt_table {\n  display: table;\n  border-collapse: collapse;\n  line-height: normal;\n  margin-left: auto;\n  margin-right: auto;\n  color: #333333;\n  font-size: 16px;\n  font-weight: normal;\n  font-style: normal;\n  background-color: #FFFFFF;\n  width: 100%;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #A8A8A8;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #A8A8A8;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n}\n\n#ohkkdbeqgg .gt_caption {\n  padding-top: 4px;\n  padding-bottom: 4px;\n}\n\n#ohkkdbeqgg .gt_title {\n  color: #333333;\n  font-size: 125%;\n  font-weight: initial;\n  padding-top: 4px;\n  padding-bottom: 4px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-bottom-color: #FFFFFF;\n  border-bottom-width: 0;\n}\n\n#ohkkdbeqgg .gt_subtitle {\n  color: #333333;\n  font-size: 85%;\n  font-weight: initial;\n  padding-top: 3px;\n  padding-bottom: 5px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-color: #FFFFFF;\n  border-top-width: 0;\n}\n\n#ohkkdbeqgg .gt_heading {\n  background-color: #FFFFFF;\n  text-align: center;\n  border-bottom-color: #FFFFFF;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#ohkkdbeqgg .gt_bottom_border {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#ohkkdbeqgg .gt_col_headings {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#ohkkdbeqgg .gt_col_heading {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: normal;\n  text-transform: inherit;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 6px;\n  padding-left: 5px;\n  padding-right: 5px;\n  overflow-x: hidden;\n}\n\n#ohkkdbeqgg .gt_column_spanner_outer {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: normal;\n  text-transform: inherit;\n  padding-top: 0;\n  padding-bottom: 0;\n  padding-left: 4px;\n  padding-right: 4px;\n}\n\n#ohkkdbeqgg .gt_column_spanner_outer:first-child {\n  padding-left: 0;\n}\n\n#ohkkdbeqgg .gt_column_spanner_outer:last-child {\n  padding-right: 0;\n}\n\n#ohkkdbeqgg .gt_column_spanner {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 5px;\n  overflow-x: hidden;\n  display: inline-block;\n  width: 100%;\n}\n\n#ohkkdbeqgg .gt_spanner_row {\n  border-bottom-style: hidden;\n}\n\n#ohkkdbeqgg .gt_group_heading {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n  text-align: left;\n}\n\n#ohkkdbeqgg .gt_empty_group_heading {\n  padding: 0.5px;\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: middle;\n}\n\n#ohkkdbeqgg .gt_from_md > :first-child {\n  margin-top: 0;\n}\n\n#ohkkdbeqgg .gt_from_md > :last-child {\n  margin-bottom: 0;\n}\n\n#ohkkdbeqgg .gt_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  margin: 10px;\n  border-top-style: solid;\n  border-top-width: 1px;\n  border-top-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n  overflow-x: hidden;\n}\n\n#ohkkdbeqgg .gt_stub {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-right-style: solid;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#ohkkdbeqgg .gt_stub_row_group {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-right-style: solid;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  padding-left: 5px;\n  padding-right: 5px;\n  vertical-align: top;\n}\n\n#ohkkdbeqgg .gt_row_group_first td {\n  border-top-width: 2px;\n}\n\n#ohkkdbeqgg .gt_row_group_first th {\n  border-top-width: 2px;\n}\n\n#ohkkdbeqgg .gt_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#ohkkdbeqgg .gt_first_summary_row {\n  border-top-style: solid;\n  border-top-color: #D3D3D3;\n}\n\n#ohkkdbeqgg .gt_first_summary_row.thick {\n  border-top-width: 2px;\n}\n\n#ohkkdbeqgg .gt_last_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#ohkkdbeqgg .gt_grand_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#ohkkdbeqgg .gt_first_grand_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-style: double;\n  border-top-width: 6px;\n  border-top-color: #D3D3D3;\n}\n\n#ohkkdbeqgg .gt_last_grand_summary_row_top {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-bottom-style: double;\n  border-bottom-width: 6px;\n  border-bottom-color: #D3D3D3;\n}\n\n#ohkkdbeqgg .gt_striped {\n  background-color: rgba(128, 128, 128, 0.05);\n}\n\n#ohkkdbeqgg .gt_table_body {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#ohkkdbeqgg .gt_footnotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#ohkkdbeqgg .gt_footnote {\n  margin: 0px;\n  font-size: 90%;\n  padding-top: 4px;\n  padding-bottom: 4px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#ohkkdbeqgg .gt_sourcenotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#ohkkdbeqgg .gt_sourcenote {\n  font-size: 90%;\n  padding-top: 4px;\n  padding-bottom: 4px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#ohkkdbeqgg .gt_left {\n  text-align: left;\n}\n\n#ohkkdbeqgg .gt_center {\n  text-align: center;\n}\n\n#ohkkdbeqgg .gt_right {\n  text-align: right;\n  font-variant-numeric: tabular-nums;\n}\n\n#ohkkdbeqgg .gt_font_normal {\n  font-weight: normal;\n}\n\n#ohkkdbeqgg .gt_font_bold {\n  font-weight: bold;\n}\n\n#ohkkdbeqgg .gt_font_italic {\n  font-style: italic;\n}\n\n#ohkkdbeqgg .gt_super {\n  font-size: 65%;\n}\n\n#ohkkdbeqgg .gt_footnote_marks {\n  font-size: 75%;\n  vertical-align: 0.4em;\n  position: initial;\n}\n\n#ohkkdbeqgg .gt_asterisk {\n  font-size: 100%;\n  vertical-align: 0;\n}\n\n#ohkkdbeqgg .gt_indent_1 {\n  text-indent: 5px;\n}\n\n#ohkkdbeqgg .gt_indent_2 {\n  text-indent: 10px;\n}\n\n#ohkkdbeqgg .gt_indent_3 {\n  text-indent: 15px;\n}\n\n#ohkkdbeqgg .gt_indent_4 {\n  text-indent: 20px;\n}\n\n#ohkkdbeqgg .gt_indent_5 {\n  text-indent: 25px;\n}\n\n#ohkkdbeqgg .katex-display {\n  display: inline-flex !important;\n  margin-bottom: 0.75em !important;\n}\n\n#ohkkdbeqgg div.Reactable > div.rt-table > div.rt-thead > div.rt-tr.rt-tr-group-header > div.rt-th-group:after {\n  height: 0px !important;\n}\n</style>\n<table class=\"gt_table\" data-quarto-disable-processing=\"false\" data-quarto-bootstrap=\"false\">\n  <thead>\n    <tr class=\"gt_heading\">\n      <td colspan=\"2\" class=\"gt_heading gt_title gt_font_normal gt_bottom_border\" style>Meta-Analysis Overview</td>\n    </tr>\n    \n    <tr class=\"gt_col_headings\">\n      <th class=\"gt_col_heading gt_columns_bottom_border gt_left\" rowspan=\"1\" colspan=\"1\" scope=\"col\" id=\"Characteristic\"></th>\n      <th class=\"gt_col_heading gt_columns_bottom_border gt_left\" rowspan=\"1\" colspan=\"1\" scope=\"col\" id=\"Value\"></th>\n    </tr>\n  </thead>\n  <tbody class=\"gt_table_body\">\n    <tr><td headers=\"Characteristic\" class=\"gt_row gt_left\">Total Studies</td>\n<td headers=\"Value\" class=\"gt_row gt_left\">57</td></tr>\n    <tr><td headers=\"Characteristic\" class=\"gt_row gt_left\">Publication Period</td>\n<td headers=\"Value\" class=\"gt_row gt_left\">2005–2025</td></tr>\n    <tr><td headers=\"Characteristic\" class=\"gt_row gt_left\">Total Patients</td>\n<td headers=\"Value\" class=\"gt_row gt_left\">~50,000+</td></tr>\n    <tr><td headers=\"Characteristic\" class=\"gt_row gt_left\">Countries Represented</td>\n<td headers=\"Value\" class=\"gt_row gt_left\">15+</td></tr>\n    <tr><td headers=\"Characteristic\" class=\"gt_row gt_left\">Prospective Cohorts</td>\n<td headers=\"Value\" class=\"gt_row gt_left\">13 (23%)</td></tr>\n    <tr><td headers=\"Characteristic\" class=\"gt_row gt_left\">Low Risk of Bias</td>\n<td headers=\"Value\" class=\"gt_row gt_left\">15 (26%)</td></tr>\n  </tbody>\n  \n</table>\n</div>\n```\n\n:::\n:::\n\n\n## Outcomes Examined\n\nThis meta-analysis investigated two primary clinical outcomes:\n\n1. **Mortality** (all-cause, typically 30-day or in-hospital)\n   - 33 effect sizes from 31 unique studies\n   - Median OR = 2.64 (IQR: 1.54–4.49)\n\n2. **Persistent Bacteremia** (microbiological clearance failure)\n   - 9 effect sizes from 7 unique studies\n   - Median OR = 2.02 (IQR: 1.25–5.73)\n\n## Analytical Approach\n\n::: {.interpretation}\n### Bayesian Framework\n\nWe employed a Bayesian random-effects framework using **brms** with weakly informative priors:\n\n- **Pooled effect (μ):** Normal(0, 1) prior on log-OR scale\n- **Between-study heterogeneity (τ):** Half-Cauchy(0, 0.5)\n- **MCMC:** 4 chains, 4000 iterations (1000 warmup)\n\nFrequentist REML models via **metafor** provided validation.\n:::\n\n### Key Analyses\n\n- ✅ Random-effects meta-analysis (Bayesian & frequentist)\n- ✅ Publication bias assessment (funnel plots, Egger's test, trim-and-fill, selection models)\n- ✅ Sensitivity analyses (outlier exclusion, prior sensitivity)\n- ✅ Meta-regression (pathogen, organism, risk of bias, blood culture system)\n- ✅ Risk of bias assessment (6 domains, 45 studies)\n\n## Heterogeneity\n\nSubstantial between-study heterogeneity was observed:\n\n- **I² = 99.3%** (mortality)\n- **τ = 0.58** (log-OR scale)\n\nMeta-regression found **no moderator significantly explained heterogeneity**, suggesting unmeasured factors (TTP cutpoint variation, patient severity, antibiotic timing) drive variability.\n\n## Publication Bias\n\n::: {.callout-warning}\n### Evidence of Funnel Asymmetry\n\n- Egger's test: **p < 0.001**\n- Trim-and-fill imputed studies: **11**\n- Only 9% of studies (3/33) were non-significant\n:::\n\nMultiple adjustment approaches were applied:\n\n| Method | Pooled OR | 95% CI/CrI | Significant? |\n|--------|-----------|------------|--------------|\n| Unadjusted | 2.18 | 1.72–2.75 | Yes |\n| Trim-and-Fill | 1.50 | 1.15–1.96 | Yes |\n| Freq. Selection | 1.09 | 0.67–1.79 | No |\n| **Bayesian Selection** | **2.14** | **1.70–2.78** | **Yes** |\n\n::: {.interpretation}\n**Interpretation:** The Bayesian selection model with regularized selection parameters suggests the true effect likely lies between OR 1.50 (conservative lower bound) and 2.14 (primary estimate). The frequentist selection model likely over-adjusts due to sparse non-significant studies.\n:::\n\n## Clinical Implications\n\nShort blood culture TTP is a readily available early prognostic marker that:\n\n- ✅ Strongly predicts increased mortality (OR ~2.14)\n- ✅ Associates with persistent bacteremia (OR ~4.02)\n- ✅ Remains significant across quality levels and sensitivity analyses\n- ✅ Could inform clinical decision-making in real-time\n\n### Potential Applications\n\n1. **Risk stratification** for intensive monitoring\n2. **Treatment escalation** decisions (e.g., source control urgency)\n3. **Prognostic counseling** for patients and families\n4. **Clinical trial enrichment** to identify high-risk patients\n\n## Study Quality\n\n\n::: {.cell}\n::: {.cell-output-display}\n![](index_files/figure-html/rob-summary-1.png){width=864}\n:::\n:::\n\n\n::: {.callout-tip}\n### Quality Assessment\n\n- 67% of studies had **moderate** overall risk of bias\n- 27% had **low** risk\n- Only 7% had **high or critical** risk\n- Risk of bias did **not modify** the TTP-mortality association in meta-regression\n:::\n\n## Navigate This Site\n\n::: {.columns}\n::: {.column width=\"48%\"}\n### Analysis Details\n- [Methods](methods.qmd) — Study selection and analytical approach\n- [Results](results.qmd) — Pooled estimates and effect sizes\n- [Forest Plots](forest_plots.qmd) — Visual summaries\n:::\n\n::: {.column width=\"48%\"}\n### Quality & Bias\n- [Risk of Bias](risk_of_bias.qmd) — Study quality assessment\n- [Publication Bias](publication_bias.qmd) — Funnel plots and selection models\n- [Discussion](discussion.qmd) — Interpretation and implications\n:::\n:::\n\n---\n\n**Last Updated:** February 13, 2026  \n**Contact:** Russell Lewis  \n**Citation:** Lewis R. Time to Positivity and Clinical Outcomes in Bacteremia: A Bayesian Meta-Analysis. 2026.\n",
    "supporting": [],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {},
    "engineDependencies": {},
    "preserve": {},
    "postProcess": true
  }
}